Antibody-drug conjugate (ADC)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Antibody-drug conjugate (ADC), covering 2024-08-23 to 2025-12-19. Get the full timeline:
Most recent: Clinical Trial Update: Antibody-based PET Imaging and Treatment Response in Breast Cancer Treated With an Antibody-drug Conjugate. [Phase 2]